A recent study by French researchers suggests that nearly 17,000 people across six countries may have died due to Hydroxychloroquine, prescribed during the first wave of
Chloroquine (CQ) and hydroxychloroquine (HCQ) have recently become the focus of global attention as possible treatments for Coronavirus Disease 2019
doi:10
Despite the potential antiviral effects and anti-inflammatory profile, the results based on clinical studies are contradictory
13 of them from the United States, 2 from Mexico, 2 from Spain and 2 from France
As of January 3, 2021, the infection was reported from 222 countries globally, 8,25,79,768 patients have been confirmed to have COVID-19, and 18,18,849 of them have died
Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial case (n=514)
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has the potential of progression into respiratory failure and death 1
Hydroxychloroquine is an anti-malaria drug that was prescribed off-label to treat COVID-19 in the early stage of the pandemic, as
uk
Chronic exposure to such drugs might lower the risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or severe coronavirus disease (COVID-19)
Spain and other places, without offering any evidence or further Introduction
Patients in the hydroxychloroquine group had a longer duration of hospitalization than those in the usual-care group (median, 16 days vs
1 Clinic of Infectious Diseases, Department of Health Science, ASST Santi Paolo e Carlo, University of Milan, Italy
3 Centre for Clinical Research, Epidemiology Norwegian coronavirus disease 2019 (NO COVID-19) pragmatic open label study to assess early use of hydroxychloroquine sulfate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial